Simple ohesity reduces peak. GH concenuations during stimulation testy in children and adults. It IS not known how factors such as sex, puheml status, stature and distribution of body fat may influence this relat~onship. We therefore retrospectively analysed the effect of percent ideal BMI (%BMI) on peak GH concentration after arginine infusion (0.5glkg) in 117 shon prepuheml children without GH deficiency (SN) and 42 prepuheml girls with Turner syndrome (TS), who had received no hormonal therapy. Physical characteristics [Mean (SD)] and regression analysis of %BMI versus log peak GH concentration are shown:
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In theye prepuhertal children, only SN girls show an inverse relauonship hetween %DM1 and peak GH concentration. There is therefore a dichotomy not only hetween girls and hoys hut also hetween SN girls and those with TS. We hypothesire that oestrogenic effects on hody compositior: may be critical to the relationsh~p hetween fat and GH secretion. The IGF-l gene contans 6 exo' ns, drstrihuted over 90kB of genome. A complex array ot mRNA species can he vanscrrhed, xhich vary in 5' (leader) and 3' (terminal) exon usage, and polyadenylation site. Four IGF-I mRNA Wanscripts encode putative preprohormones: IGF-lA (exons 1,3,4,6), the dominant species expressed in liver, IGF-IB (exons 1,3,4.5), IGF-IA' (exons 2,3,4,6) and IGF-IB' (exons 2,3,4,5). Interest has focured on the differential expression of these mRNAs, their relevance to IGF-I action and hormonal mechanisms, which may induce their expresrion. The Laron syndrome is characterised by insensitivity to the actions of GH. Hence the IGF-I gene w~l l be expressed independent of GH control. We have therefore examined the expression of the IGF-I gene in total RNA exuacted from confluent skin fihrohlast cultures, taken from 3 children with Laron syndrome and 1 normal chlld. This was achieved by reverse transcription of mRNA followed hy PCR amplification of the 4 wanscripts with oligonucleotide primers specific to 5' (exons I or 2) or 3' (exons 5 or 6) IGF-I sequences. IGF-IA and IB mRNA were expressed In 2 of the 3 Larons and the normal child, and IGF-lB mRNA only in the oldest of the Laron children. Transcripts containing the alternative leader exon 2 were not identified. Fibroblass from those with Laron syndrome may form an important tissue in which to study IGF-I gene expression Independent of GH action. As a basis for assessment of the clinical validity of urinary GH measurements in children, the variahility in renal handling of GH was compared to that of creatinine in 93 healthy chlldren (aged 4-16 years), 20 of normal stature and 73 with growth disorders. 10 were classified as GH deficient (GHD), 48 as shon normal (SN) and 15 had Turner syndrome (TS). 5 overnight urine samples were collected over 2 weeks, and the vanahility of excretion expressed as a coefficient of variation (CV) of the total overnight amount of GH or creatinine. There was considerahle night to night variahility in the excretion of hoth substances: * p < 0.05 compared to Normal + SN, # p<0.05
TIIE INSULIN-LIKEGROWTH FACTOR-I (IGF-I) GENE IS EXPRESSED
Creatinine 36' compared to Normal. Assay varratlon rat er an a c ange In rena protein handling accounted for the large variation in low UGH cnncenuations, thus contributing to the high UGH CV of the GHD group. Increasing thc numher of samples collected (upto 5) decreased the expected sample variation (error) for UGH hut not significantly in all groups, and reduced the convenience and practicality of the test. These resullr indicate that variation in GH and creatinine excretion is considerahle in hoth normal children and those with gn~wth disorders. The use of multiple samples (upto 5) does not significantly reduce the variahility inherent in UGH measurement. nor plasma basal hGH secretion ( mean 19,9 mUlll to 20. 9 mUI/I ) .
We concluded that u-hGH is of good predictive value for the diagnosis of LARON dwarfism but is not affected by IGF 1 therapy, despite growth acceleration. The role of lGFl in the feed back regulation of GH secretion in Laron dwarfism remains questionnable. TPP reduces adult height. During its first year of administration. the LH RH agonist D-Trp6 (DecapeptylO) decreased growth velocity and bone maturation, but its long term effects have not been analyzed. Fourteen girls had onset of idiopathic TPP at 6.3t1.2 yrs: their growth rate was 9.7f3.5 cmlyr and bone age 8.9f1.9 yr. The girls received 1 injectionlmo of a depot preparation of the agonist during 4.851.2 yrs. Growth rate stabilized at 4f1.2 cm per yr (p<O.O05 vs pretreatment) and bone age increased by only 0.85+0.15 yrlyr. At the end of treatment, height was 151.5+6.2 cm and bone age 12.3t0.6 yrs. Growth rate remained at 4.4f2 cmlyr during the following 6-34 months. Therefore. 7f1.3 yrs after the onset of treatment with the LH-RH agonist, height was 157f8 cm and bone age 13.2f1.1 yrs, producing a final height prognosis of 162f5 cm. We conclude that treatment of true precocious puberty with D-Trp6-LH-RH increases final height prognosis.
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